Acting as lead joint book running managers
are Morgan Stanley & Co LLC and Credit Suisse Securities (USA) LLC; also act as joint book running manager
is BofA Merrill Lynch; Barclays Capital Inc and Jefferies LLC will act as book running managers
; and Cowen and Company LLC, Guggenheim Securities LLC, Raymond James & Associates Inc and William Blair & Company LLC will act as co-managers for this offering that will be made under the registration statement after it becomes effective.
12 August 2014 - Financial services firm Leerink Partners LLC said it is acting as sole book running manager
for a proposed initial public offering by Danish biopharmaceutical firm Forward Pharma A/S.
The acting lead book-running manager is Goldman, Sachs & Co, acting book running manager
is Stifel Nicolaus & Company Incorporated and acting co-managers are Pacific Crest Securities LLC, BMO Capital Markets Corp, Needham & Company LLC and Raymond James & Associates Inc.
The acting lead book-running manager was Credit Suisse Securities (USA) LLC, acting book running managers
were Barclays Capital Inc and JP Morgan Securities LLC and the acting co-managers were JMP Securities LLC and Keefe Bruyette & Woods Inc.